Quality problems that result in adverse outcomes provide opportunities for quality improvement.
Patient suffers central nervous system damage after prolonged use of metoclopramide and ranitidine hydrochloride to control gastroesophageal reflux. Treatment is complicated by poor communication among providers and omissions in history-taking.
D000328:Adult; D000897:Anti-Ulcer Agents / Q000009:adverse effects*; D000932:Antiemetics / Q000009:adverse effects*; D003266:Continuity of Patient Care; D004359:Drug Therapy, Combination; D004409:Dyskinesia, Drug-Induced / Q000209:etiology*; D005260:Female; D005764:Gastroesophageal Reflux / Q000188:drug therapy; D006801:Humans; D008787:Metoclopramide / Q000009:adverse effects*; D011899:Ranitidine / Q000009:adverse effects*; D012308:Risk Management; D017749:Total Quality Management
D000897:Anti-Ulcer Agents; D000932:Antiemetics; D011899:Ranitidine; D008787:Metoclopramide